Bronchioloalveolar Carcinoma (Lepidic Growth) Component Is a More Useful Prognostic Factor than Lymph Node Metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bronchioloalveolar Carcinoma (Lepidic Growth) Component Is a More Useful Prognostic Factor than Lymph Node Metastasis

Published:2009-08 Issue:8 Volume:4 Page:951-958
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Anami Yoichi,Iijima Tatsuo,Suzuki Kenji,Yokota Jun,Minami Yuko,Kobayashi Hiromi,Satomi Kaishi,Nakazato Yoshimasa,Okada Masafumi,Noguchi Masayuki

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib;Hirsch;Ann Oncol,2007

2. Nuclear p53 accumulation by small-sized adenocarcinomas of the lung;Kawasaki;Pathol Int,1996

3. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer;Komaki;Int J Radiat Oncol Biol Phys,1998

4. Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor;Lee;J Clin Oncol,1995

5. Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer;Sculier;J Clin Oncol,1985

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer ≤ 2 cm: a systematic review and patient-level meta-analysis;Updates in Surgery;2023-08-10

2. Lepidic growth component as a favorable prognostic factor in non–small cell lung cancer of ≤3 cm;Thoracic Cancer;2022-10-11

3. FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow;Lung Cancer;2021-07

4. Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma;Tumori Journal;2020-09-02

5. The prognostic effect of TTF-1 expression in the Chinese population of patients with advanced lung adenocarcinomas;Translational Lung Cancer Research;2020-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3